-- Preview Email Newsletter
Public Policy Tipoffs Involving Arizona Newsletter for 2025-07-21 ( 4 items ) |
Coalition Urges Rescission of Wildlife Refuge Policy Changes (10)
WASHINGTON, July 21 -- The Coalition of Arizona/New Mexico Counties has submitted a public comment letter to the U.S. Department of the Interior, urging the agency to rescind the recent policy changes affecting the National Wildlife Refuge System (NWRS). The letter, supported by a coalition of counties and various local industries, asserts that the current administration's policies undermine local involvement and threaten economic opportunities tied to mineral exploration and land use.
The coal more ST
SpinSys-Dine Submits Recommendations for CMS Health Technology Ecosystem (10)
WASHINGTON, July 21 -- SpinSys-Dine, Scottsdale, Arizona, submitted a public comment letter to the Centers for Medicare & Medicaid Services (CMS) regarding its Health Technology Ecosystem. The company, which specializes in cybersecurity, health IT, cloud computing, artificial intelligence (AI), and data management, offered insights based on its two decades of supporting federal health systems.
SpinSys-Dine emphasized its experience with the Military Health System (MHS) and Defense Health Agency more ST
State Officials Endorse Army Corps' Nationwide Permits, Seek Swift Action (10)
WASHINGTON, July 20 -- The U.S. Army Corps of Engineers received a public comment letter from a coalition of state officials expressing strong support for the proposal to reissue and modify Nationwide Permits (NWPs) under the Clean Water Act. The states involved include Alabama, Alaska, Arkansas, Florida, Georgia, Iowa, Indiana, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, North Dakota, Oklahoma, South Carolina, Tennessee, Texas, Utah, Virginia, West Virginia, and the A more ST
Tulane University: FDA-backed Metric Used to Determine Effectiveness of Rectal Cancer Drugs May Be Unreliable, Says Study (10)
NEW ORLEANS, Louisiana, July 19 (TNSjou) -- Tulane University issued the following news release:
* * *
An FDA-backed metric used to determine effectiveness of rectal cancer drugs may be unreliable, says new study
A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without evidence they help patients live longer.
The study, published in JAMA Network Open in col more PR
|